Steven C. Bishop

Array ( [id] => 11895205 [patent_doc_number] => 09765130 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-09-19 [patent_title] => 'Glucagon/GLP-1 agonists for the treatment of obesity' [patent_app_type] => utility [patent_app_number] => 14/650469 [patent_app_country] => US [patent_app_date] => 2013-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15981 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14650469 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12322788 [patent_doc_number] => 09943571 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-04-17 [patent_title] => Use of ultrarapid acting insulin [patent_app_type] => utility [patent_app_number] => 14/102383 [patent_app_country] => US [patent_app_date] => 2013-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 28 [patent_no_of_words] => 27480 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14102383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12367344 [patent_doc_number] => 09957316 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-05-01 [patent_title] => Weight loss by inhibition of gastrokine [patent_app_type] => utility [patent_app_number] => 14/652488 [patent_app_country] => US [patent_app_date] => 2013-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 4059 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14652488 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10933335 [patent_doc_number] => 20140336356 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-13 [patent_title] => 'PEPTIDE AGONISTS OF GLP-1 ACTIVITY' [patent_app_type] => utility [patent_app_number] => 14/095667 [patent_app_country] => US [patent_app_date] => 2013-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 28985 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14095667 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10405319 [patent_doc_number] => 20150290328 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-15 [patent_title] => 'FORMULATIONS OF ACTIVE AGENTS FOR SUSTAINED RELEASE' [patent_app_type] => utility [patent_app_number] => 14/646273 [patent_app_country] => US [patent_app_date] => 2013-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 10055 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14646273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10560705 [patent_doc_number] => 09284364 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-15 [patent_title] => 'Isolated nucleic acid molecule encoding a fusion protein comprising an activin receptor' [patent_app_type] => utility [patent_app_number] => 14/085056 [patent_app_country] => US [patent_app_date] => 2013-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 13666 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 245 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14085056 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10380677 [patent_doc_number] => 20150265684 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-24 [patent_title] => 'METHODS OF TREATING HEMOGLOBINOPATHIES' [patent_app_type] => utility [patent_app_number] => 14/646284 [patent_app_country] => US [patent_app_date] => 2013-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10810 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14646284 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9294065 [patent_doc_number] => 20140037699 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-06 [patent_title] => 'SOLUBLE NON-DEPOT INSULIN CONJUGATES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/055911 [patent_app_country] => US [patent_app_date] => 2013-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 32221 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14055911 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9463892 [patent_doc_number] => 20140128319 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-08 [patent_title] => 'INSULIN ANALOGUES CONTAINING PENTA-FLUORO-PHENYLALANINE AT POSITION B24' [patent_app_type] => utility [patent_app_number] => 14/046620 [patent_app_country] => US [patent_app_date] => 2013-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 21315 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14046620 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9307075 [patent_doc_number] => 20140045749 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-13 [patent_title] => 'GROWTH FACTOR COMPLEX' [patent_app_type] => utility [patent_app_number] => 14/032848 [patent_app_country] => US [patent_app_date] => 2013-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12465 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14032848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10129249 [patent_doc_number] => 09163075 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-20 [patent_title] => 'Isolated polynucleotide that encodes an ActRIIa-Fc fusion polypeptide' [patent_app_type] => utility [patent_app_number] => 14/027542 [patent_app_country] => US [patent_app_date] => 2013-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 25 [patent_no_of_words] => 20906 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14027542 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9546730 [patent_doc_number] => 20140171377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-19 [patent_title] => 'NOVEL PEPTIDES THAT ENHANCE TIGHT JUNCTION PERMEABILITY' [patent_app_type] => utility [patent_app_number] => 14/023103 [patent_app_country] => US [patent_app_date] => 2013-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11797 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14023103 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9330536 [patent_doc_number] => 20140057318 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-27 [patent_title] => 'POLYNUCLEOTIDE AND POLYPEPTIDE SEQUENCE AND METHODS THEREOF' [patent_app_type] => utility [patent_app_number] => 13/973130 [patent_app_country] => US [patent_app_date] => 2013-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6586 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13973130 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9363691 [patent_doc_number] => 20140073564 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-13 [patent_title] => 'PROTEASE STABILIZED, ACYLATED INSULIN ANALOGUES' [patent_app_type] => utility [patent_app_number] => 13/973183 [patent_app_country] => US [patent_app_date] => 2013-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 44897 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13973183 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9363179 [patent_doc_number] => 20140073052 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-13 [patent_title] => 'MODULATION OF GRANULOSA CELL APOPTOSIS' [patent_app_type] => utility [patent_app_number] => 13/968359 [patent_app_country] => US [patent_app_date] => 2013-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 40744 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13968359 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12942673 [patent_doc_number] => 09833516 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-12-05 [patent_title] => Liquid formulation of long-acting insulin and insulinotropic peptide [patent_app_type] => utility [patent_app_number] => 14/416231 [patent_app_country] => US [patent_app_date] => 2013-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 10620 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14416231 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9148924 [patent_doc_number] => 20130303447 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-14 [patent_title] => 'METHODS FOR PREVENTING OR TREATING INSULIN RESISTANCE' [patent_app_type] => utility [patent_app_number] => 13/946921 [patent_app_country] => US [patent_app_date] => 2013-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 17842 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13946921 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9134375 [patent_doc_number] => 20130295089 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-07 [patent_title] => 'METHOD OF PROMOTING BONE GROWTH BY AN ANTI-ACTRIIA ANTIBODY' [patent_app_type] => utility [patent_app_number] => 13/939976 [patent_app_country] => US [patent_app_date] => 2013-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 22476 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13939976 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9122036 [patent_doc_number] => 20130288958 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-31 [patent_title] => 'Novel Glucagon Analogues' [patent_app_type] => utility [patent_app_number] => 13/937674 [patent_app_country] => US [patent_app_date] => 2013-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 30586 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13937674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9951130 [patent_doc_number] => 08999917 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-07 [patent_title] => 'Variant activin receptor polypeptides and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/932421 [patent_app_country] => US [patent_app_date] => 2013-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 16 [patent_no_of_words] => 21712 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13932421 [rel_patent_id] =>[rel_patent_doc_number] =>)